Literature DB >> 21717193

The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study.

T G Liman1, G Bohner, P U Heuschmann, M Endres, E Siebert.   

Abstract

The aim of the study was to characterize the clinical and radiological spectrum of posterior reversible encephalopathy syndrome (PRES) in a large cohort. The radiological report data bases of the authors' university hospitals were searched for patients with PRES. Various imaging features at onset of symptoms and on follow-up as well as clinical and paraclinical data were tabulated in those patients fulfilling the criteria for PRES. Exploratory univariate analyses were performed. A total of 96 patients with PRES were included into the study. Wide differences in lesion location, diffusivity, distribution pattern, edema severity, hemorrhage, underlying diseases, symptoms, mean arterial pressure (MAP) and coagulation status were encountered. Hemorrhage occurred significantly more frequently in patients with altered coagulation state and was significantly associated with higher edema grades and with the presence of cytotoxic edema. There was a significant difference in MAP between toxic associations with higher MAP in infection, eclampsy and autoimmune disorders, while lower MAP was found in chemotherapy and immunsupression. In 82% of patients complete or near complete resolution of edema was noted during follow-up. Higher MAP levels were associated with incomplete edema resolution. In 43% of patients residual lesions were seen with a relatively even distribution between focal gliosis, infarction, posthemorrhagic residua, atrophy and laminar necrosis. PRES in this large hospital-based retrospective study comprises a wide radiological and clinical spectrum. Residual lesions were encountered more frequently than commonly expected. Our results point towards a differential contribution of high blood pressure to the course of PRES in different underlying etiologies.

Entities:  

Mesh:

Year:  2011        PMID: 21717193     DOI: 10.1007/s00415-011-6152-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Reversible posterior leukoencephalopathy syndrome: what have we learned in the last 10 years?

Authors:  Judith A Hinchey
Journal:  Arch Neurol       Date:  2008-02

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 3.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

4.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

5.  Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.

Authors:  H M Hefzy; W S Bartynski; J F Boardman; D Lacomis
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

6.  The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.

Authors:  A Benigni; M Morigi; N Perico; C Zoja; C S Amuchastegui; A Piccinelli; R Donadelli; G Remuzzi
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

7.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings.

Authors:  Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  Vivien H Lee; Eelco F M Wijdicks; Edward M Manno; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-02

10.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

View more
  56 in total

1.  Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.

Authors:  Carlos Kamiya-Matsuoka; Asif M Paker; Linda Chi; Ayda Youssef; Sudhakar Tummala; Monica E Loghin
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

2.  Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome.

Authors:  Hui Li; Ying Liu; Jing Chen; Xia Tan; Xiu-Yun Ye; Ming-Sheng Ma; Jian-Ping Huang; Li-Ping Zou
Journal:  World J Pediatr       Date:  2015-06-04       Impact factor: 2.764

3.  Acute cortical blindness caused by pre-eclampsia in the antepartum; posterior reversible encephalopathy syndrome (PRES).

Authors:  Wang Yacong; Cao Qinying; Zhang Lihong; Zhang Su'e; Shi Liang; Sha Ou
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

Review 5.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

6.  A case of posterior reversible encephalopathy syndrome in a patient undergoing automated peritoneal dialysis.

Authors:  Shohei Kaneko; Keiji Hirai; Saori Minato; Katsunori Yanai; Yuko Mutsuyoshi; Hiroki Ishii; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Taro Hoshino; Susumu Ookawara; Yoshiyuki Morishita
Journal:  CEN Case Rep       Date:  2019-03-04

7.  Acute chorea in posterior reversible encephalopathy syndrome.

Authors:  Jeong-Jin Park; Jong-Hyeon Ahn; Choong-Kun Ha; Eun-Kee Bae
Journal:  J Neurol       Date:  2012-10-18       Impact factor: 4.849

Review 8.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

Review 9.  [Posterior reversible encephalopathy syndrome].

Authors:  D Staykov; S Schwab
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

10.  Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES).

Authors:  Julia Kunzmann; Hubert Wolf; Stefan Oberndorfer
Journal:  BMJ Case Rep       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.